Clearstead Advisors’s Core Scientific Inc Tranche 2 Warrants CORZZ Stock Holding History

Clearstead Advisors’s Portfolio CORZZ Stock Details CORZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Sell	48,000 -15,318	-24%	-$360K	0.01%	506
2026 Q1	$950K	Buy	+63,318	New	+$1.08M	0.01%	533
2025 Q2	–	Sell	-3	Closed	-$22	–	2763
2025 Q1	$22	Hold	3	–	–	﹤0.01%	2178
2024 Q4	$43	Hold	3	–	–	﹤0.01%	2069
2024 Q3	$36	Sell	3 -101,102	-100%	-$1.04M	﹤0.01%	2017
2024 Q2	$879K	Buy	+101,105	New	+$386K	0.02%	417

Other funds holding CORZZ

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Clearstead Advisors's CORZZ Position: Q2 2026 in Review

Clearstead Advisors reduced its Core Scientific Inc Tranche 2 Warrants (CORZZ) stake by 24% in Q2 2026, selling an estimated $360K and leaving 48,000 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #506.

Clearstead Advisors first reported a position in CORZZ in Q2 2024 and has held it in 6 quarters since. 30 funds tracked by Wall St. Rank hold CORZZ as of Q2 2026.

Clearstead Advisors held 48,000 shares of Core Scientific Inc Tranche 2 Warrants worth $1.2M as of Q2 2026.
Clearstead Advisors sold 15,318 Core Scientific Inc Tranche 2 Warrants shares in Q2 2026, an estimated $360K.
Core Scientific Inc Tranche 2 Warrants made up 0.01% of Clearstead Advisors's portfolio in Q2 2026, its #506 holding.
Clearstead Advisors first reported a position in Core Scientific Inc Tranche 2 Warrants in Q2 2024 and has held it in 6 quarters since.
30 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 2 Warrants as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.